Pediatrics in Review Note to Institutions for Site Subscriptions
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Pediatrics in Review. 1988;10:140-159.)
© 1988 American Academy of Pediatrics

This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Enzyme Multiplied Immunoassay Test

The enzyme multiplied immunoassay (EMIT) is a widely used analytical drug screening method that has been marketed for use by nonlaboratory personnel. The technique relies on the measurement of an enzyme's ability to modify a substrate. In its most common form, lysozyme that has been labeled with the suspected drug is added to the urine specimen along with a bacterial suspension and antibody to the suspected drug. If no drug is present, the antibody to the drug will bind with the druglysozyme ysozyme complex, thereby inactivating the lysozyme and failing to affect the turbidity of the suspension. If drug is present, the antibody to the drug will bind with both the enzyme-labeled drug and the free drug, leaving some of the enzyme-labeled drug complex free to act on the bacteria in the suspension, thus modifying the turbidity of the solution.







HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics  Pediatrics in Review
Copyright © 1988 by the American Academy of Pediatrics.